Newron Pharmaceuticals
NWRN.SW
#8320
Rank
โ‚ฌ0.14 B
Marketcap
7,71ย โ‚ฌ
Share price
-1.10%
Change (1 day)
61.73%
Change (1 year)

EPS for Newron Pharmaceuticals (NWRN.SW)

EPS in 2023: -1,03ย โ‚ฌ

According to Newron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,03ย โ‚ฌ. In 2023 the company made an earnings per share (EPS) of -1,03ย โ‚ฌ a decrease over its 2022 EPS that were of -1,01ย โ‚ฌ.

EPS history for Newron Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023-1,03ย โ‚ฌ2.03%
2022-1,01ย โ‚ฌ15.39%
2021-0,88ย โ‚ฌ-31.32%
2020-1,28ย โ‚ฌ14.74%
2019-1,11ย โ‚ฌ36.6%
2018-0,82ย โ‚ฌ159.87%
2017-0,31ย โ‚ฌ-67.81%
2016-0,97ย โ‚ฌ-39.24%
2015-1,60ย โ‚ฌ107.61%
2014-0,77ย โ‚ฌ15.8%
2013-0,67ย โ‚ฌ119.91%
2012-0,30ย โ‚ฌ-66.51%
2011-0,91ย โ‚ฌ-71.49%
2010-3,18ย โ‚ฌ-10.83%
2009-3,56ย โ‚ฌ42.06%
2008-2,51ย โ‚ฌ56.53%
2007-1,60ย โ‚ฌ-52.84%
2006-3,40ย โ‚ฌ-188.53%
20053,84ย โ‚ฌ